Sperlix Pharma Private Limited
About Sperlix Pharma Private Limited
Data last updated:
Sperlix Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 April 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24230HR2022PTC102875.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prakash Chand and Hitesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. 222 Village Saketri Satsang Bhawan, Panchkula, Haryana, India – 134114.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹65,708 (net margin 0.6%) and EBITDA of ₹1.24 Lakh (EBITDA margin 1.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sperlix Pharma Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressH.No. 222 Village Saketri Satsang Bhawan, Panchkula, Haryana, India – 134114
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sperlix Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sperlix Pharma Private Limited, buy the company report.
Financials of Sperlix Pharma Private Limited
FY 2025 filings availableSperlix Pharma Private Limited reported revenue of ₹1.01 Cr (up 812% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 812% in the latest year. EBITDA rose 191% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.24 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹65,708 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.2% | ||
| Net Profit Margin | 0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sperlix Pharma Private Limited, buy the company report.
Board of directors of Sperlix Pharma Private Limited
Sperlix Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Chand | Director | 18 Apr 2022 | 4 Years 6 Months | Current |
| Hitesh Kumar | Director | 18 Apr 2022 | 4 Years 6 Months | Current |
Peer comparison
Sperlix Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yashpal Agrotech Private Limited | ₹1.01 Cr (FY 2024) | 4.0% | Lucknow, Uttar Pradesh, India | |||
| Quadrangle Trading Services Private Limited | ₹1.01 Cr (FY 2014) | Chennai, Tamil Nadu, India | ||||
| Gayatri International Limited | ₹1.01 Cr (FY 2025) | -66.0% | Hyderabad, Telangana, India | |||
| Gitapb Ink and Art Colours Private Limited | ₹1.01 Cr (FY 2025) | 153.0% | Vadodara, Gujarat, India | |||
| Jkpharma Life Science Private Limited | ₹1.01 Cr (FY 2025) | 16.0% | Pune, Maharashtra, India | |||
| Sperlix Pharma Private Limitedthis company | ₹1.01 Cr (FY 2025) | ₹65,708 | 0.6% | 812.0% | Panchkula, Haryana, India | |
| Vedhaa Phoenix Private Limited | ₹1.01 Cr (FY 2025) | -15.0% | Madurai, Tamil Nadu, India | |||
| Debarati Goods Private Limited | ₹1.01 Cr (FY 2025) | 1733.0% | Kolkata, West Bengal, India | |||
| Aims Technologies Private Limited | ₹1.01 Cr (FY 2024) | -34.0% | Johri Pur Extension, Delhi, India | |||
| Asha Clothing Private Limited | ₹1.01 Cr (FY 2025) | -13.0% | Ahmedabad, Gujarat, India | |||
| Adsc Instrumentation Private Limited | ₹1.01 Cr (FY 2022) | -2.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Sperlix Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sperlix Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sperlix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sperlix Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sperlix Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Hitesh Kumar was appointed as Director on 18 Apr 2022.
Frequently asked questions
Sperlix Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 April 2022 (4+ years old) and is registered under CIN U24230HR2022PTC102875.
Sperlix Pharma has 2 current directors:
- Prakash Chand - Director
- Hitesh Kumar - Director
The latest financial statements of Sperlix Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Sperlix Pharma is U24230HR2022PTC102875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sperlix Pharma was incorporated on 18 April 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Sperlix Pharma by revenue are Yashpal Agrotech Private Limited, Quadrangle Trading Services Private Limited, Gayatri International Limited, Gitapb Ink and Art Colours Private Limited, Jkpharma Life Science Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Hitesh Kumar was appointed as Director on 18 Apr 2022. Prakash Chand was appointed as Director on 18 Apr 2022.
The registered office of Sperlix Pharma is at H.No. 222 Village Saketri Satsang Bhawan, Panchkula, Haryana, India – 134114.
Sperlix Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Sperlix Pharma is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Sperlix Pharma can be reached at its registered office: H.No. 222 Village Saketri Satsang Bhawan, Panchkula, Haryana, India – 134114.